Pharmaceutical Industry: “It’s time to give France a biomanufacturing champion”
[Translated in English from a tribune published in the French newspaper L’Opinion on October 27th 2022].
The health crisis has demonstrated with a brutality that has shocked – and sometimes bruised – many of our fellow citizens: Europe, and in particular France, has lost control of the supply chain of its health products, particularly of some of its Medicines of Major Therapeutic Interest (MMTI).